跳至主要内容
临床试验/NCT00137293
NCT00137293终止2 期

A Study to Characterize the Acute Electrophysiologic Properties, Safety and Tolerability of GAP-486

Wyeth is now a wholly owned subsidiary of Pfizer7 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2005年11月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
发起方
入组人数
30
试验地点
7
主要终点
This study takes place within 24 hours. The measure to determine the effect of the intervention will be the difference in values from the baseline electrophysiology study, and the values obtained after intervention within the test drug.

研究概览

简要总结

The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing an electrophysiology study for evaluation of heart rhythm.

排除标准

  • Patients with uncontrolled blood pressure
  • Patients with certain cardiac risk factors
  • Patients with significant kidney or liver problems

结局指标

主要结局

This study takes place within 24 hours. The measure to determine the effect of the intervention will be the difference in values from the baseline electrophysiology study, and the values obtained after intervention within the test drug.

次要结局

  • This study takes place within 24 hours, and looks at the changes in values of electrophysiology studies, before and after administration of test article.

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry

研究点 (7)

Loading locations...

相似试验